MY108498A - Phenethanolamine derivatives. - Google Patents

Phenethanolamine derivatives.

Info

Publication number
MY108498A
MY108498A MYPI89000633A MYPI19890633A MY108498A MY 108498 A MY108498 A MY 108498A MY PI89000633 A MYPI89000633 A MY PI89000633A MY PI19890633 A MYPI19890633 A MY PI19890633A MY 108498 A MY108498 A MY 108498A
Authority
MY
Malaysia
Prior art keywords
group
integer
formula
oxygen
sulphur atom
Prior art date
Application number
MYPI89000633A
Inventor
Naylor Alan
Finch Harry
Henry Charles Lunts Lawrence
Frederick Skidmore Ian
Leonard Mitchell William
Hartley David
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to MYPI89000633A priority Critical patent/MY108498A/en
Publication of MY108498A publication Critical patent/MY108498A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE INVENTION PROVIDES COMPOUNDS OF THE GENERAL FORMULA (1) (FORMULA 1) AND PHYSIOLOGICALLY ACCEPTABLE SALTS AND SOLVATES THEREOF, WHEREIN AR REPRESENTS THE GROUP (FORMULA 2) WHERE Q1 REPRESENTS A STRAIGHT OR BRANCHED C1-3 ALKYLENE GROUP, (FORMULA 3) WHERE Q2 REPRESENTS A GROUP R3CO-, R3NHCO-, R3R4NSO2- OR R5SO2-, WHERE R3 AND R4 EACH REPRESENT A HYDROGEN ATOM OR A C1-3ALKYL GROUP, AND R5 REPRESENTS A C1-3ALKYL GROUP, (FORMULA 4) R REPRESENTS A HYDROGEN ATOM OR A C1-3ALKYL GROUP; RI AND R2 EACH INDEPENDENTLY REPRESENT A HYDROGEN ATOM OR A METHYL OR ETHYL GROUP; AND K REPRESENTS AN INTEGER FROM 1 TO 8; M REPRESENTS ZERO OR AN INTEGER FROM 2 TO 7, AND; N REPRESENTS AN INTEGER FROM 1 TO 7 WITH THE PROVISO THAT THE SUM TOTAL OF K, M AND N IS 4 TO 12; X REPRESENTS AN OXYGEN OR SULPHUR ATOM, AND; Y AND Z EACH REPRESENT A BOND, OR AN OXYGEN OR SULPHUR ATOM WITH THE PROVISO THAT WHEN Y IS A BOND M IS ZERO, OR WHEN Y REPRESENTS AN OXYGEN OR SULPHUR ATOM M IS AN INTEGER FROM 2 TO 7, OR WHEN Y AND Z EACH INDEPENDENTLY REPRESENT AN OXYGEN OR SULPHUR ATOM THEN N IS AN INTEGER FROM 2 TO 7; Q REPRESENTS A NAPHTHALENYL GROUP WHICH MAY OPTIONALLY BE SUBSTITUTED BY ONE OR TWO GROUPS SELECTED FROM C1-4ALKYL, C1-4ALKOXY, HYDROXY AND HALOGEN. THE COMPOUNDS HAVE A STIMULANT ACTION AT ?2- ADRENORECEPTORS AND MAY BE USED IN THE TREATMENT OF DISEASES ASSOCIATED WITH REVERSIBLE AIRWAYS OBSTRUCTION SUCH AS ASTHMA AND CHRONIC BRONCHITIS.
MYPI89000633A 1989-05-11 1989-05-11 Phenethanolamine derivatives. MY108498A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI89000633A MY108498A (en) 1989-05-11 1989-05-11 Phenethanolamine derivatives.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI89000633A MY108498A (en) 1989-05-11 1989-05-11 Phenethanolamine derivatives.

Publications (1)

Publication Number Publication Date
MY108498A true MY108498A (en) 1996-10-31

Family

ID=79553773

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI89000633A MY108498A (en) 1989-05-11 1989-05-11 Phenethanolamine derivatives.

Country Status (1)

Country Link
MY (1) MY108498A (en)

Similar Documents

Publication Publication Date Title
HK85790A (en) Dichloroaniline derivatives
EP0303465A3 (en) Phenethanolamine derivatives
IE883400L (en) Phenethanolamine derivatives
ES8505641A1 (en) A PROCEDURE FOR THE PREPARATION OF PHENETHANOLAMINE DERIVATIVES.
DE60019904D1 (en) USE OF SULPHATE DERIVATIVES FOR THE TREATMENT OF IMPULSE DISORDER
ES8400388A1 (en) Nitrogen containing 2,3-dihydro naphthalenes, compositions and use
SE8501895D0 (en) FENETANOLAMINFORENINGAR
EP0230629A3 (en) 2-propylamino-tetralin derivatives for reducing intraocular pressure
YU68792A (en) PROCEDURE FOR THE PREPARATION OF BAKATIN III AND 10-DESACETYL-BAKATINA III DERIVATIVES
FI930974A0 (en) SUBSTITUTE AMINOPHOSPHONATDERIVAT, FOERFARANDE FOER FRAMSTAELLNING AV DESAMMA OCH PHARMACEUTICAL COMPOSITION INNEHAOLLANDE DESAMMA
ES8609216A1 (en) A PROCEDURE FOR THE PREPARATION OF AMINOPHENOL DERIVATIVES.
EP0398720A3 (en) Piperazine derivatives
DE69323322D1 (en) USE OF DIMETHYLBENZOFURAN AND DIMETHYLBENZOPYRAN DERIVATIVES AS 5-HT3 ANTAGONISTE
ES8303279A1 (en) Derivatives of phenyl aliphatic carboxylic acids, and use thereof in treating gastric and gastro-duodenal ailments
ES8301196A1 (en) Cinnamoyl-cinnamic acid derivative, its preparation and its use as a therapeutic agent.
EP0385446A3 (en) Osteogenesis promotion with use of vitamin d derivatives
AU631865B2 (en) Phenethanolamine derivatives, processes for their preparation and pharmaceutical compositions containing them
ES469961A1 (en) Chromene derivatives useful as bronchodilators and anti-arrhythmics
EP0387661A3 (en) New 3'-(4-morpholinyl)- and 3'-(2-methoxy-4-morpholinyl)-anthracycline derivatives
GB8718939D0 (en) Chemical compounds
ES533657A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF PYRROLLO- (2,1-A) ISOQUILONINA.
MY101756A (en) Dichloroaniline derivatives
ES555619A0 (en) A PROCEDURE FOR PREPARING THIOIMIDAZOLE DERIVATIVES
EP0278728A3 (en) 1-(4-amino-3,5-dichlorophenyl)-2-(substituted amino)ethanol derivatives and their use in the treatment of respiratory disease
ES8802416A1 (en) New 4-substd.-2,6-di:chloro-aniline cpds.